EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages

Rodrigo Díaz-Pino, Gillian I Rice iD, Diego San Felipe iD, Tamar Pepanashvili, Paul R Kasher iD, Tracy A Briggs, Gloria López-Castejón iD

Life Science Alliance · 2024-06 · 7 (6) · e202302399

DOI: 10.26508/lsa.202302399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 25.03.2024. Verfasst von Rodrigo Díaz-Pino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The Univer…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Interferon Type I. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI | Medical Research Council, National Institute for Health and Care Research, Agencia Nacional de Investigación y Desarrollo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammasomes are immune complexes whose activation leads to the release of pro-inflammatory cytokines IL-18 and IL-1β. Type I IFNs play a role in fighting infection and stimulate the expression of IFN-stimulated genes (ISGs) involved in inflammation. Despite the importance of these cytokines in inflammation, the regulation of inflammasomes by type I IFNs remains poorly understood. Here, we analysed RNA-sequencing data from patients with monogenic interferonopathies and found an up-regulation of several inflammasome-related genes. To investigate the effect of type I IFN on the inflammasome, we treated human monocyte-derived macrophages with IFN-α and observed an increase in CASP1 and GSDMD mRNA levels over time, whereas IL1B and NLRP3 were not directly correlated to IFN-α exposure time. IFN-α treatment reduced the release of mature IL-1β and IL-18, but not caspase-1, in response to ATP-mediated NLRP3 inflammasome activation, suggesting regulation occurs at cytokine expression levels and not the inflammasome itself. However, more studies are required to investigate how regulation by IFN-α occurs and impacts NLRP3 and other inflammasomes at both transcriptional and post-translational levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInterferon Type IHumansInflammasomesInterleukin-1betaInterleukin-18MacrophagesCytokinesInflammationCaspase 1

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesInterleukin-1betaInterferon Type IInterleukin-18CytokinesCaspase 1

Autor:innen und Institutionen

  • Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
  • School of Biological Sciences, Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Department of Genomic Medicine, St Marys Hospital, Manchester Foundation Trust, Manchester, UK.
  • Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Department of Physiology, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
  • Geoffrey Jefferson Brain Research Centre, The Manchester Academic Health Science Centre, Northern Care Alliance and The University of Manchester, Manchester, UK.

ORCID-Profile: Gillian I Rice, Diego San Felipe, Paul R Kasher, Gloria López-Castejón

Förderung

  • UKRI | Medical Research Council
  • National Institute for Health and Care Research
  • Agencia Nacional de Investigación y Desarrollo
  • NIHR Manchester
  • Complutense University of Madrid and Banco Santander

Zitieren

APA

Díaz-Pino, R., Rice, G. I., San Felipe, D., Pepanashvili, T., Kasher, P. R., Briggs, T. A., & López-Castejón, G. (2024). Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages. Life Science Alliance, 7(6), e202302399. https://doi.org/10.26508/lsa.202302399

Vancouver

Díaz-Pino R, Rice GI, San Felipe D, Pepanashvili T, Kasher PR, Briggs TA, et al. Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages. Life Science Alliance. 2024;7(6):e202302399. doi:10.26508/lsa.202302399

BibTeX
@article{DazPino2024,
  author = {Díaz-Pino, Rodrigo and Rice, Gillian I and San Felipe, Diego and Pepanashvili, Tamar and Kasher, Paul R and Briggs, Tracy A and López-Castejón, Gloria},
  title = {Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages},
  journal = {Life Science Alliance},
  year = {2024},
  volume = {7},
  number = {6},
  pages = {e202302399},
  doi = {10.26508/lsa.202302399}
}
Kostenlos starten →